Shortages of name-brand obesity drugs sparked a surge in online sales of compounded alternatives. In a recent NPR report, AACE President Scott D. Isaacs, MD, FACP, FACE, expressed concern about these products, warning that they have not been proven safe or effective. Without FDA oversight, there's no guarantee that these actually work, and there can be dosing errors.